| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer
2 companies
Heery Christopher is a Chief Medical Officer at Arcellx, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $2.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 14, 2026 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 5,882 | $68.51 | $402,997.00 | -19.9% | +64.4% | - | |
| Jan 13, 2026 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 7,437 | $65.51 | $487,212.74 | -20.1% | +72.0% | - | |
| Jan 12, 2026 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 6,131 | $64.15 | $393,285.87 | -14.2% | +77.0% | - | |
| Nov 17, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sell | 340 | $90.00 | $30,600.00 | -54.5% | -22.3% | - | |
| Sep 30, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sell | 21,034 | $81.28 | $1,709,722.59 | -52.4% | -20.7% | - | |
| Sep 29, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sell | 73 | $80.16 | $5,851.68 | -0.3% | -17.7% | - | |
| Sep 26, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sell | 12,396 | $80.12 | $993,155.12 | -36.3% | -17.6% | - | |
| Sep 19, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sell | 3,643 | $80.01 | $291,468.42 | -5.0% | -17.6% | - | |
| Feb 24, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 10,155 | $63.79 | $647,772.62 | -7.9% | -1.7% | +80.5% | |
| Jan 8, 2025 | ACLX Arcellx, Inc. | Chief Medical Officer | Sale+OE | 7,783 | $74.69 | $581,315.58 | -12.7% | -25.8% | -11.0% |